首页> 外文OA文献 >Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

【2h】

Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

机译：羟考酮一次性控制释放片剂的设计和体内评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Eun-Seok Park; Ju-Young Kim; Sung-Hoon Lee; Chun-Woong Park; Yun-Seok Rhee; Dong-Wook Kim; Junsang Park; Moonseok Lee; Jeong-Woong Seo;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 羟考酮/纳洛酮控释片与羟考酮控释片治疗韩国癌性疼痛患者的疗效及安全性的随机对照研究 [J] . Kyung-He Lee, Min Kyoung Kim, Yong Sang Hong, 癌症（英文版） . 2018,第005期
2. Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets [J] . Ju-Young Kim, Sung-Hoon Lee, Chun-Woong Park, Drug Design, Development and Therapy . 2015,第9期

机译：羟考酮每日一次控释片的设计与体内评价
3. The effect of FDA approval of a generic competitor to OxyContin (oxycodone HCl controlled-release) tablets on the abuse of oxycodone. [J] . Bailey JE, Barton PL, Lezotte D, Drug and alcohol dependence . 2006,第2期

机译：FDA批准仿制竞争对手OxyContin（盐酸羟考酮控释）片剂对滥用羟考酮的影响。
4. Onset of analgesic effect and plasma levels of controlled-release tramadol (Tramadol Contramid once-a-day) 200-mg tablets in patients with acute low back pain. [J] . Sarbu A, Radulescu F, Robertson S Journal of opioid management . 2008,第5期

机译：急性下腰痛患者的镇痛作用和血浆中曲马多（曲马多避孕药每天一次）200 mg片剂的血浆水平。
5. Comparison of different in vitro and in vivo methods for evaluating the mucoadhesion of Poly(acrylic acid)-Cysteine tablets to stomach [C] . Zeynep Ay Senyigit, Anja Vetter, Tamer Guneri, Annual meeting exposition of the Controlled Release Society . 2010

机译：评价聚（丙烯酸）-半胱氨酸片剂对胃粘膜粘附性的不同体内外方法的比较
6. (1) Development and in vivo testing of a gastric retention device (GRD) in dogs, (2) Product formulations and in vitro-in vivo evaluation of, (a) immediate release formulation of itraconazole, (b) controlled-release formulation of ketoprofen in adults [D] . Kapsi, Shivakumar G. 1999

机译：（1）在犬中开发胃滞留装置（GRD）并进行体内测试；（2）（a）伊曲康唑的速释制剂，（b）依他康唑的控释制剂的产品配方和体内体外评估成人酮洛芬
7. Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets [O] . Ju-Young Kim, Sung-Hoon Lee, Chun-Woong Park, 2015

机译：羟考酮每日一次控释片的设计与体内评价
8. MS3 ECONOMIC EVALUATION OF CONTROLLED-RELEASE OXYCODONE (OXYCONTIN®TABLETS) (CRO) VERSUS OXYCODONE/ACETAMINOPHEN (PERCOCET®) (OXY/APAP) FOR OSTEOARTHRITIS PAIN OF THE HIP OR KNEE [O] . Marshall DA, Strauss ME, Pericak D, 2005

机译：MS3髋关节或膝关节骨痛性疼痛的控释羟考酮（OXYCONTIN®片剂）（CRO）与羟考酮/乙胺磷（PERCOCET®）（OXY / APAP）的经济评价

Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

著录项

引文网络

相似文献

相关主题

期刊订阅